Infection Surveillance Solutions Market Size, Share & Trends Analysis Report By Product & Services (Software (On-premise Software, Web-based Software), Up to 50 hp (Product Support & Maintenance Services, Implementation Services, Training & Consulting services), By End User, By Region, And By Segment Forecasts, 2023-2031
The Infection Surveillance Solutions Market Size is valued at USD 544.93 Mn in 2022 and is predicted to reach USD 1581.37 Mn by the year 2031 at a 12.7 % CAGR during the forecast period for 2023-2031.
The term "infection surveillance solutions" refers to systems continuously tracking and managing information on healthcare-associated infections (HAIs) for public health evaluation. The effective implementation of preventative interventions depends on the early recognition of sickness. The two main factors pushing the growth of the infection surveillance solutions systems market are the rise in microbial resistance to antibiotics and the increased usage of automation in healthcare settings.
The rise in hospital-associated illnesses, such as urinary tract infections, surgical site infections, and poor sanitation, drives the market for infection surveillance solutions. Furthermore, The rise in the practice of self-medication, the expansion of IT systems' analytical processing capabilities, and non-adherence to prescribed medication all impact the market for infection surveillance systems.
Additionally, the market for infection surveillance solutions is positively impacted by government initiatives in the form of policies, an increase in healthcare spending, an increase in the number of surgeries, and research and development activities. On the other hand, the market expansion for infection surveillance solutions is anticipated to be hampered by the high cost of the software, medical professionals' resistance to utilizing cutting-edge healthcare products, and a shortage of operating skilled it professionals.
Competitive Landscape:
Some major key players in the Infection Surveillance Solutions Market:
- Becton, Dickinson and Company (US)
- Premier, Inc. (US)
- Wolters Kluwer N.V. (Netherlands)
- Cerner Corporation (US)
- Baxter International Inc. (US)
- GOJO Industries, Inc. (US)
- Clinisys (US)
- Deb Group Ltd. (UK)
- BioVigil Healthcare Systems (US)
- RLDatix (UK)
- Merative (US)
- Vecna Technologies, Inc. (US)
- VigiLanz Corporation (US)
- Ecolab (US)
- Harris Healthcare (US)
- PeraHealth (US)
- Medexter Healthcare (Austria)
- CenTrak, Inc. (US)
- bioMerieux SA (France)
- CKM Healthcare (Canada)
- Asolva Inc. (US)
- PointClickCare (Canada)
- STANLEY Healthcare (US)
- Vitalacy Inc. (US)
- VIZZIA Technologies (US)
Market Segmentation:
The infection surveillance solutions market is segmented on the basis of products & services, and End-User. Based on the product & services, the segmentation is as software which includes on-premise and web-based software and up to 50 hp, which consists of product support & maintenance services, implementation services and training & consulting services). Based on End-User, the market segments are hospitals (large, medium-sized hospitals, and small hospitals), long-term care facilities (nursing homes, skilled nursing facilities and assisted-living facilities), and other end users.
Based On Products & Services, The Software Segment Is Accounted As A Major Contributor In The Infection Surveillance Solutions Market
The software category will hold a major share of the global market in 2022. Technology development has contributed to this rise by enabling efficient patient data management, research, and comprehension. Elation Health is a cloud-based, clinically focused solution for doctors looking for an ONC-ATCB-approved electronic medical record (EMR), including patient appointments, a patient portal, e-prescribing, and e-faxing. Electronic medical records are progressively being utilized as part of the software segment because of the benefits the cloud provides, such as cheaper maintenance costs, enhanced collaboration, good backup and restore data capabilities, and more convenience.
The Hospitals Segment Witnessed a fast Growth Rate
The segment, hospital, is estimated to grow rapidly in the global infection surveillance solutions market. Hospitals have significant purchasing power, and their involvement in the system-building process has contributed to their dominance. In addition, hospitals have stronger HAI management skills and can monitor patients within the allotted period. Over 45% of hospitals are thought to use software and surveillance systems for speedier illness analysis. They installed automated technologies to examine historical infection patterns through simulation, aiding in the containment of healthcare-acquired illnesses in healthcare institutions.
In The Region, The North America Infection Surveillance Solutions Market Holds A Significant Revenue Share
The North American infection surveillance solutions market is expected to record the major market share in revenue. The stricter regulations and the substantial number of companies providing infection surveillance solutions in North America are driving factors in the market for these products. The prevalence of HAIs in the U.S. and Canada is on the rise, and this, combined with strong government measures, is anticipated to fuel regional market expansion.
To tackle germs that are resistant to antibiotics, such as the prevalence of Clostridium difficile, Carbapenem-resistant Enterobacteriaceae, and methicillin-resistant Staphylococcus aureus, the National Action Plan (NAP), a five-year action plan, was introduced. In addition, Asia-Pacific is expected to grow at the quickest rate. The primary forces in the area are the growing public awareness of health issues, rising healthcare spending, increased healthcare facilities, and quick advancements in health insurance.
Infection Surveillance Solutions Market Report Scope:
| Report Attribute | Specifications |
| Market Size Value In 2022 | USD 544.93 Mn |
| Revenue Forecast In 2031 | USD 1581.37 Mn |
| Growth Rate CAGR | CAGR of 12.7 % from 2023 to 2031 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
| Historic Year | 2019 to 2022 |
| Forecast Year | 2023-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product & Services, By End-User |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia |
| Competitive Landscape | Becton, Dickinson and Company (US), Premier, Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US), Baxter International Inc. (US), GOJO Industries, Inc. (US), Clinisys (US), Deb Group Ltd. (UK), BioVigil Healthcare Systems (US), RLDatix (UK), Merative (US), Vecna Technologies, Inc. (US), VigiLanz Corporation (US), Ecolab (US), Harris Healthcare (US), PeraHealth (US), Medexter Healthcare (Austria), CenTrak, Inc. (US), bioMerieux SA (France), CKM Healthcare (Canada), Asolva Inc. (US), PointClickCare (Canada), STANLEY Healthcare (US), Vitalacy Inc. (US), and VIZZIA Technologies (US). |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Infection Surveillance Solutions Market-
Infection Surveillance Solutions Market By Product & Services
- Software
- On-premise Software
- Web-based Software
- Up to 50 hp
- Product Support & Maintenance Services
- Implementation Services
- Training & Consulting services
Infection Surveillance Solutions Market By End User
- Hospitals
- Large Hospitals
- Medium Sized Hospitals
- Small Hospitals
- Long-term Care Facilities
- Nursing Homes
- Skilled Nursing Facilities
- Assisted- Living Facilities
- Other End Users
Infection Surveillance Solutions Market By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Infection Surveillance Solutions Market Size is valued at USD 544.93 Mn in 2022 and is predicted to reach USD 1581.37 Mn by the year 2031
Infection Surveillance Solutions Market expected to grow at a 12.7 % CAGR during the forecast period for 2023-2031
Becton, Dickinson and Company (US), Premier, Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US), Baxter International Inc. (US), GO
Product & Service and End-User are the key segments of the Infection Surveillance Solutions Market.
North American region is leading the Infection Surveillance Solutions Market.